BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 28483532)

  • 1. Pro-resolving mediators in the regulation of periodontal disease.
    Van Dyke TE
    Mol Aspects Med; 2017 Dec; 58():21-36. PubMed ID: 28483532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve?
    Van Dyke TE; Sima C
    Periodontol 2000; 2020 Feb; 82(1):205-213. PubMed ID: 31850636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting the paradigm from inhibitors of inflammation to resolvers of inflammation in periodontitis.
    Van Dyke TE
    J Periodontol; 2020 Oct; 91 Suppl 1(Suppl 1):S19-S25. PubMed ID: 32441774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.
    Salvi GE; Beck JD; Offenbacher S
    Ann Periodontol; 1998 Jul; 3(1):40-50. PubMed ID: 9722689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory mediators in the pathogenesis of periodontitis.
    Yucel-Lindberg T; Båge T
    Expert Rev Mol Med; 2013 Aug; 15():e7. PubMed ID: 23915822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases.
    Van Dyke TE; Serhan CN
    J Dent Res; 2003 Feb; 82(2):82-90. PubMed ID: 12562878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of inflammation in periodontal disease.
    Van Dyke TE
    J Periodontol; 2008 Aug; 79(8 Suppl):1601-8. PubMed ID: 18673016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Microbial Interactions in Systemic Lupus Erythematosus and Periodontitis.
    Pessoa L; Aleti G; Choudhury S; Nguyen D; Yaskell T; Zhang Y; Li W; Nelson KE; Neto LLS; Sant'Ana ACP; Freire M
    Front Immunol; 2019; 10():2602. PubMed ID: 31781106
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory Mediators in Periodontal Pathogenesis.
    Huck O; Buduneli N; Bravo D
    Mediators Inflamm; 2019; 2019():2610184. PubMed ID: 31316297
    [No Abstract]   [Full Text] [Related]  

  • 10. Proresolution mediators and receptors: novel drug targets for enhancing pharmacological armamentarium against periodontal inflammation.
    Grover V; Malhotra R; Kapoor A; Singh J; Sachdeva S
    Infect Disord Drug Targets; 2013 Feb; 13(1):75-84. PubMed ID: 23713671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Neutrophil Homing to the Periodontal Tissues Modulates the Composition and Disease Potential of the Oral Microbiota.
    Hashim A; Alsam A; Payne MA; Aduse-Opoku J; Curtis MA; Joseph S
    Infect Immun; 2021 Nov; 89(12):e0030921. PubMed ID: 34491788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal diseases: pathogenesis.
    Offenbacher S
    Ann Periodontol; 1996 Nov; 1(1):821-78. PubMed ID: 9118282
    [No Abstract]   [Full Text] [Related]  

  • 13. Resolution of inflammation in periodontitis.
    Kantarci A; Van Dyke TE
    J Periodontol; 2005 Nov; 76(11 Suppl):2168-74. PubMed ID: 16277590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular aspects of the pathogenesis of periodontitis.
    Meyle J; Chapple I
    Periodontol 2000; 2015 Oct; 69(1):7-17. PubMed ID: 26252398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm shift in the pharmacological management of periodontal diseases.
    Hasturk H; Kantarci A; Van Dyke TE
    Front Oral Biol; 2012; 15():160-76. PubMed ID: 22142963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.
    Suárez LJ; Garzón H; Arboleda S; Rodríguez A
    Front Immunol; 2020; 11():591255. PubMed ID: 33363538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proresolving lipid mediators: potential for prevention and treatment of periodontitis.
    Van Dyke TE
    J Clin Periodontol; 2011 Mar; 38 Suppl 11():119-25. PubMed ID: 21323709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.